SAN FRANCISCO — In his third year as CEO of Bristol Myers Squibb, Chris Boerner kicked off the JP Morgan Healthcare Conference with plans for six pivotal readouts of new drugs …
Read More from Endpoints News
#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook
